Routine inducement grants have no near-term trading implications. Monitor for any future updates on employee retention or material changes in insider ownership.
SNDX drugs
SNDX drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 5 $17.34entry
- T+1 · 5mo ago −2.19%α −2.42% · $16.96
- T+5 · 5mo ago +5.25%α +4.68% · $18.25
- T+20 · 4mo ago +27.34%α +25.47% · $22.08
- T+60 · 3mo ago +11.25%α +7.25% · $19.29
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Syndax Pharmaceuticals granted inducement awards for 66,700 shares to four new employees under the 2023 Inducement Plan. The stock options vest over four years with a one-year cliff. This is a routine compensation event with no material impact on the company's financials or operations.
Key Facts
- Inducement awards granted on June 1, 2026
- 66,700 shares of common stock awarded to four new employees
- Options vest over four years with 25% after one year and monthly thereafter
Financial Impact
Minimal; 66,700 shares represent less than 0.1% of outstanding shares based on market cap of $1.6B
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3307077 |
Track record
16 reports on SNDX
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $9.45 Now $9.13 −3.39% settles Feb 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $9.49 Now $9.13 −3.79% settles Feb 8
- Nov 9, 20267d ago Press Release Neutral 2/10 Entry $9.49 Now $9.13 −3.79% settles Feb 8
- Nov 2, 202614d ago 8-K Neutral 5/10 No price data
- Nov 2, 202614d ago Press Release Neutral 2/10 No price data
- Nov 2, 202614d ago Press Release Neutral 5/10 Entry $14.29 Now $9.13 −36.11% settles Feb 1
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $13.65 Now $9.13 −33.11% settles Jan 28
- Jul 14, 202617w ago 8-K Bullish 7/10 Entry $24.13 to $17.03 Now $9.13 −62.16% ▼ −29.42% −32.80% vs SPY
- Jul 1, 202619w ago Press Release Neutral 2/10 Entry $21.82 to $18.20 Now $9.13 −58.16% ▼ −16.59% −20.16% vs SPY
- Jun 11, 202622w ago Press Release Bullish 7/10 Entry $17.91 to $20.56 Now $9.13 −49.02% ▲ +14.80% +10.40% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers